Lasolvan syrup 30mg/5ml

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

ambroxol (ambroxol hydrochloride)

Available from:

Boehringer Ingelheim Espana S.A.

INN (International Name):

ambroxol (ambroxol hydrochloride)

Dosage:

30mg/5ml

Pharmaceutical form:

syrup

Prescription type:

OTC

Summary of Product characteristics

ffi
Boehri
nger
\lllllt/
Ingelhe
im
Product
iDforu.tion
r.
NAME
OF
TIIE
MEDICINAL
PRODUCT
Lasolvan@
syrup
30
mg/5
mJ
Active
sobsJaoc€:
Ambroxol
hydrochloride
2.
QUALITATIVE
AND
QUANTITATTVD COMPOSITION
5
ml
of
syrup
contains
30
mg
ambroxol
hydrochloride,
For
the
full
l
ist
of
e*cipients'
see
section
6
l
r.i,i,tirfii
,r
r::r:r
ir,
3.
PITARMACEUTTCAL
F,oRM
IxPinlill,tri-
o6/ss
at.'ll
Syrup
fororal
use
jl'
l'.
1
r'=>
&
(a29/F-
4.
CLINICALPARTICULARS
4,1
TlrerapeuticlDdicatioN
se"'erol,'tic
th€rapy
in
acute
and
crronic
bronchopurmonary
diseasgs
associated
with
abnormar
hucDs
secretion
and
impaired
mucus
FansDorr
acute
ani
chronjciron;d;,;i;;;r;'ffi;ic
obstructive
pulmonary
disease,
bronchial
asthmi,
broncnrecrauc
orsease_
4.2
Po6olog/
and
mclhod
ofadministrstion
Unless
othorwise
prescribed,
the.
fo;lowing
doses
are
rccommended
for
Lasolvar
syrup
3
0
mgl5
rn
l:
Childle
undel
2
yearc
o/-d,.this
medicine
is
contraiudicated
forchildren
under2
years
oio.
Children
frotn
2
o
5
yars
ol
ape
:
l15
ml
tbree
times
daity
lequiialenr
ro ZZ.5
mg
arnbroxot
hydrochloride/day)
Chtldrenlrom
6
ro
I2
yea$
ofage:
2.5
ml two
to
three
tinres
daii
(;quivalenr
to
30
_
45
m8
ambro{oj
h)drochloride/day)
Aduhs
and
odolescenx
over
12
years
ofage;
rne
usuat
dose
is
5
ml
ttfee
tjmes
dailv
feouiv?lent
to
90
mg
ambroxol
hydrochloride/day)
for
rhe
firsr
2
-
3 days
and
5
mt
rwice
daity (equivaienrio
60
mg
"rnb.oiol
hyd,;"hio;ij;rrr';"##:.
For€dr
ts
and
adolescents
over
12
years
ofage.
the
therapeuric
effecr
may
be
enhanced
by
increasing
tne
dose
ro
l0
ml twice
daity
(equj!ajenr
ro
l20
mg
ambroxot
hldrochlorid,€./day).
Page
I
of?
Lasolvan
syrup
30
mg/5
ml
can
be taken
with
or
without lood
and is
dispensed
with
the
aid
of
the
measuring
cup
provided.
There is
no
lestriction
in
principle
on
the duration
ofuse,
although longer-term
administration
r€quires
medicai supervision.
The
packa8e
leafler informs patients
that
l,asolvan
syrup
30
mg/5
mt
should
not
be
taken
lor
more
than
4
- 5 days
without
medical advicc.
Lasolvan
syrr.rp
30
rng/5
ml
is suit